OptiNose, Inc.
OPTN · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -17.4% | 9.7% | -0.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 90.5% | 91.3% | 89.9% | 90.3% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -40.7% | 20.3% | 28.5% | -12.5% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -121.1% | -1.6% | 2.3% | -37% |
| EPS Diluted | -1.92 | -0.031 | 0.034 | -1.05 |
| % Growth | -6,113.6% | -191.4% | 103.2% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |